EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dermofat Graft Implantation in Post-Axillary Dissection Defects for Lymphatic Regeneration, Lymphedema Prevention and Reconstruction in Breast Cancer: A Case Series

Suyatno Suyatno, Muhammad Rusda, Kamal Basri Siregar, Adi Muradi Muhar, Denni Joko Purwanto, Iqbal Pahlevi Adeputra Nasution, Selvi Nafianti, Ferryan Sofyan, Muhammad Al Anas

F1000Research · 19.04.2026 · 15 · 583

DOI: 10.12688/f1000research.178722.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, online erschienen am 19.04.2026. Verfasst von Suyatno Suyatno und 8 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lymphedema remains a debilitating complication following axillary lymph node dissection (ALND) in breast cancer surgery, with limited effective preventive strategies available, particularly in low-resource settings. Dermofat graft (DFG) implantation, an autologous technique combining dermis and adipose tissue, has emerged as a potential method to restore tissue volume, and promote lymphangiogenesis. This study evaluates the feasibility, safety, and preliminary efficacy of DFG implantation in preventing lymphedema and reconstructing surgical defects following ALND in breast cancer patients.

Methods

A prospective case series was conducted involving seven female breast cancer patients (aged 44–66 years) undergoing modified radical mastectomy (MRM) or breast-conserving surgery (BCS) with ALND. Intraoperative DFGs harvested from the lower abdomen were implanted into axillary and/or breast defects. Outcomes included arm volume measurements (preoperatively and at 1, 3, and 6 months), incidence of lymphedema (International Society of Lymphology criteria), lymphoscintigraphy for lymphatic regeneration, and postoperative complications.

Results

Across all seven cases, no early-stage lymphedema (stage 0–II) was observed at six months postoperatively. Lymphoscintigraphy performed in four patients (57.1%) demonstrated new lymphatic vessel formation. Minor complications included seroma with partial fat lysis (n = 2) and transient fever (n = 1), all of which resolved without long-term sequelae. Cosmetic outcomes were favorable, with improved axillary contour and preserved breast symmetry in BCS cases.

Conclusion

Dermofat graft implantation is a feasible and safe technique that may simultaneously prevent lymphedema and enhance reconstructive outcomes in breast cancer surgery. DFG offers a resource-efficient alternative to microsurgical procedures, particularly valuable in low- and middle-income settings.

Zitieren

APA

Suyatno, S., Rusda, M., Siregar, K. B., Muhar, A. M., Purwanto, D. J., Nasution, I. P. A., Nafianti, S., Sofyan, F., & Anas, M. A. (2026). Dermofat Graft Implantation in Post-Axillary Dissection Defects for Lymphatic Regeneration, Lymphedema Prevention and Reconstruction in Breast Cancer: A Case Series. F1000Research, 15, 583. https://doi.org/10.12688/f1000research.178722.1

Vancouver

Suyatno S, Rusda M, Siregar KB, Muhar AM, Purwanto DJ, Nasution IPA, et al. Dermofat Graft Implantation in Post-Axillary Dissection Defects for Lymphatic Regeneration, Lymphedema Prevention and Reconstruction in Breast Cancer: A Case Series. F1000Research. 2026;15:583. doi:10.12688/f1000research.178722.1

BibTeX
@article{Suyatno2026,
  author = {Suyatno, Suyatno and Rusda, Muhammad and Siregar, Kamal Basri and Muhar, Adi Muradi and Purwanto, Denni Joko and Nasution, Iqbal Pahlevi Adeputra and Nafianti, Selvi and Sofyan, Ferryan and Anas, Muhammad Al},
  title = {Dermofat Graft Implantation in Post-Axillary Dissection Defects for Lymphatic Regeneration, Lymphedema Prevention and Reconstruction in Breast Cancer: A Case Series},
  journal = {F1000Research},
  year = {2026},
  volume = {15},
  pages = {583},
  doi = {10.12688/f1000research.178722.1}
}
Kostenlos starten →